Camber-logo (Camber Logo)
Darunavir Tablet, Film Coated
Product Images NDC 31722-568
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 31722-568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Darunavir-400-mg-container (Darunavir 400 mg Container)
Darunavir 400 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label includes dosage form, strength, NDC code 31722-567-60, package count of 60 tablets, storage instructions, a pharmacist dispensing note, and manufacturer information including Hetero Labs in India. A blank varnish area noted for batch coding is also visible.*
Darunavir-600-mg-container (Darunavir 600 mg Container)
Darunavir Tablets 600 mg film coated oral tablets label from Camber Pharmaceuticals, Inc. The label indicates 60 tablets per container, includes a barcode, storage instructions at 20° to 25°C, and warnings for pharmacists and patients regarding dispensing and medication alerts. Manufactured by Camber Pharmaceuticals, with additional manufacturing by Hetero Labs Limited, India.*
Spironolactone-os-figure-1 (Spironolactone Os Figure 1)
A scatter plot with error bars showing geometric mean ratios (GMR) and 90% confidence intervals for Darunavir/Ritonavir twice daily in second and third trimesters. The variables measured include AUC Total, Cmin Total, AUC Unbound, and Cmin Unbound, with GMR values and confidence intervals indicated numerically on the right.*
Spironolactone-os-figure-2 (Spironolactone Os Figure 2)
A forest plot chart showing geometric mean ratios (GMR) with 90% confidence intervals for Darunavir/Ritonavir once daily dosing during the second and third trimesters. The chart compares pharmacokinetic parameters including total AUC, total Cmin, unbound AUC, and unbound Cmin, with values presented for each trimester group.*
Spironolactone-os-structure (Spironolactone Os Structure)
Chemical structure diagram of Darunavir showing its molecular composition and arrangement of atoms, consistent with its identity as the active ingredient in the product Darunavir.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
